Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study …
B Zheng, ACA Green, J Tazare, HJ Curtis, L Fisher… - medRxiv, 2022 - medrxiv.org
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
vs. molnupiravir (an antiviral) in preventing severe COVID-19 outcomes in non-hospitalised …
vs. molnupiravir (an antiviral) in preventing severe COVID-19 outcomes in non-hospitalised …
[HTML][HTML] Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study …
B Zheng, ACA Green, J Tazare, HJ Curtis, L Fisher… - The BMJ, 2022 - ncbi.nlm.nih.gov
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
[HTML][HTML] Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort …
B Zheng, AC Green, J Tazare, HJ Curtis, L Fisher… - 2022 - europepmc.org
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
vs. molnupiravir (an antiviral) in preventing severe COVID-19 outcomes in non-hospitalised …
vs. molnupiravir (an antiviral) in preventing severe COVID-19 outcomes in non-hospitalised …
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …
B Zheng, ACA Green, J Tazare… - BMJ (Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
[HTML][HTML] Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study …
B Zheng, ACA Green, J Tazare, HJ Curtis, L Fisher… - BMJ, 2022 - bmj.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …
B Zheng, ACA Green, J Tazare… - BMJ: British Medical …, 2022 - search.proquest.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …
B Zheng, ACA Green, J Tazare… - BMJ (Clinical …, 2022 - researchonline.lshtm.ac.uk
OBJECTIVE: To compare the effectiveness of sotrovimab (a neutralising monoclonal
antibody) with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult …
antibody) with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult …
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study …
B Zheng, ACA Green, J Tazare, HJ Curtis, L Fisher… - medRxiv, 2022 - medrxiv.org
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
vs. molnupiravir (an antiviral) in preventing severe COVID-19 outcomes in non-hospitalised …
vs. molnupiravir (an antiviral) in preventing severe COVID-19 outcomes in non-hospitalised …
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …
B Zheng, ACA Green, J Tazare, HJ Curtis… - … (Clinical Research ed …, 2022 - europepmc.org
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …